Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.74 USD
-17.54%
Market Closed
Updated:
May 21, 2024
Compugen Ltd
Net Change in Cash
|
Compugen Ltd
Net Change in Cash Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Net Change in Cash
$9.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Net Change in Cash
-$1.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Net Change in Cash
-₪8.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
See Also
What is Compugen Ltd's Net Change in Cash?
Net Change in Cash
9.3m
USD
9.3m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Net Change in Cash amounts to 9.3m USD.
What is Compugen Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-3%
-3%
Over the last year, the Net Change in Cash growth was 221%. The average annual Net Change in Cash growth rates for Compugen Ltd have been 40% over the past three years , and -3% over the past ten years .
You don't have any saved screeners yet
